  In this study, we present Flatsomatic - a Variational Auto Encoder (VAE)
optimized to compress somatic mutations that allow for unbiased data
compression whilst maintaining the signal. We compared two different neural
network architectures for the VAE: Multilayer Perceptron (MLP) and
bidirectional LSTM. The somatic profiles we used to train our models consisted
of 8,062 Pan-Cancer patients from The Cancer Genome Atlas and 989 cell lines
from the COSMIC cell line project. The profiles for each patient were
represented by the genomic loci where somatic mutations occurred and, to reduce
sparsity, the locations with a frequency <5 were removed. We enhanced the VAE
performance by changing its evidence lower bound, and devised an F1-score based
loss showing that it helps the VAE learn better than with binary cross-entropy.
We also employed beta-VAE to weight the variational regularisation term in the
loss function and showed the best performance through a preliminary function to
increase the weight of the regularisation term with each epoch. We assessed the
reconstruction ability of the VAE using the micro F1-score metric and showed
that our best performing model was a 2-layer deep MLP VAE. Our analysis also
showed that the size of the latent space did not have a significant effect on
the VAE learning ability. We compared the Flatsomatic embeddings created to a
lower dimension version of the data from principal component analysis, showing
superior performance of Flatsomatic, and performed K-means clustering on both
datasets to draw comparisons to known cancer types of each profile. Finally, we
present results that confirm that the Flatsomatic representations of 64
dimensions maintain the same predictive power as the original 8,298 dimensions
vector, through prediction of drug response.
